World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
98
Citations
65243
World Ranking
8727
National Ranking
491

Overview

Ulrich Costabel is affiliated with the University of Duisburg-Essen in Germany and has a focused research profile in pulmonary and respiratory medicine. Their work primarily addresses interstitial lung diseases and idiopathic pulmonary fibrosis, where they have made significant academic contributions. Costabel's research spans 163 publications in medicine, with 94 focused on pulmonary and respiratory medicine, alongside interests in physiology, epidemiology, public health, environmental and occupational health, and pathology and forensic medicine.

The scientist's main research topics include:

  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Sarcoidosis and Beryllium Toxicity Research
  • Inhalation and Respiratory Drug Delivery
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Occupational Exposure and Asthma
  • Medical Imaging and Pathology Studies
  • Systemic Sclerosis and Related Diseases

Frequent publication venues for Costabel include:

  • Pneumologie
  • European Respiratory Journal
  • Respiration
  • The Lancet Respiratory Medicine
  • Frontiers in Immunology

Notable recent papers by Ulrich Costabel feature prominent studies in respiratory disease management and treatment recommendations, including:

  • "Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial" (2021), published in The Lancet Respiratory Medicine
  • "Progressive fibrosing interstitial lung disease: clinical uncertainties, consensus recommendations, and research priorities" (2020), published in The Lancet Respiratory Medicine
  • "Delphi consensus recommendations for a treatment algorithm in pulmonary sarcoidosis" (2020), published in European Respiratory Review
  • "Hypersensitivity pneumonitis" (2020), published in Nature Reviews Disease Primers
  • "Ziritaxestat, a Novel Autotaxin Inhibitor, and Lung Function in Idiopathic Pulmonary Fibrosis" (2023), published in JAMA

Costabel has collaborated extensively with several co-authors, including:

  • Francesco Bonella
  • Michael Kreuter
  • Dirk Koschel
  • Antje Prasse
  • Jürgen Behr

These collaborations have supported interdisciplinary approaches in pulmonary research, combining clinical insights and therapeutic innovation. Ulrich Costabel's scientific output reflects a field-centered investigation into chronic lung diseases, emphasizing both clinical trial participation and consensus-building efforts in treatment guidelines.

Best Publications

  • An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-Based Guidelines for Diagnosis and Management

    Ganesh Raghu;Harold R. Collard;Jim J. Egan;Fernando J. Martinez

  • American thoracic society/European respiratory society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias

    William D. Travis;Talmadge E. King;Eric D. Bateman;David A. Lynch

  • Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis

    Luca Richeldi;Roland M. du Bois;Ganesh Raghu;Arata Azuma

  • An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias

    William D. Travis;Ulrich Costabel;David M. Hansell;Talmadge E. King

  • Idiopathic pulmonary fibrosis : Diagnosis and treatment. International consensus statement

    Jr King;U. Costabel;J. F. Cordier;G. A. DoPico

  • Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials.

    Paul W Noble;Carlo Albera;Williamson Z Bradford;Ulrich Costabel

  • ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders.

    Hunninghake Gw;Costabel U;Ando M;Baughman R

  • High-Dose Acetylcysteine in Idiopathic Pulmonary Fibrosis

    Maurits Demedts;Juergen Behr;Roland Buhl;Ulrich Costabel

  • Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis.

    Luca Richeldi;Ulrich Costabel;Moises Selman;Dong Soon Kim

  • An Official American Thoracic Society Clinical Practice Guideline: The Clinical Utility of Bronchoalveolar Lavage Cellular Analysis in Interstitial Lung Disease

    Keith C. Meyer;Ganesh Raghu;Robert P. Baughman;Kevin K. Brown

  • Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement.

    Robert P. Baughman;Marjolein Drent;Mani Kavuru;Marc A. Judson

  • Clinical diagnosis of hypersensitivity pneumonitis.

    Yves Lacasse;Moises Selman;Ulrich Costabel;Jean Charles Dalphin

  • European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis

    S R Johnson;J F Cordier;R Lazor;R Lazor;V Cottin

  • Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial

    Talmadge E King;Carlo Albera;Williamson Z Bradford;Ulrich Costabel

  • Forced vital capacity in patients with idiopathic pulmonary fibrosis: test properties and minimal clinically important difference.

    Roland M. du Bois;Derek Weycker;Carlo Albera;Williamson Z. Bradford

  • Six-minute-walk test in idiopathic pulmonary fibrosis: test validation and minimal clinically important difference.

    Roland M. du Bois;Derek Weycker;Carlo Albera;Williamson Z. Bradford

  • Quantitative analysis of mycobacterial and propionibacterial DNA in lymph nodes of Japanese and European patients with sarcoidosis.

    Yoshinobu Eishi;Moritaka Suga;Ikuo Ishige;Daisuke Kobayashi

  • Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections.

    Victor Corman;Marcel Müller;U. Costabel;J. Timm

  • Ascertainment of individual risk of mortality for patients with idiopathic pulmonary fibrosis.

    Roland M. du Bois;Derek Weycker;Carlo Albera;Williamson Z. Bradford

  • The WASOG Sarcoidosis Organ Assessment Instrument: An update of a previous clinical tool

    Marc A. Judson;Ulrich Costabel;Marjolein Drent;Athol Wells

Frequent Co-Authors

Paul W. Noble
Paul W. Noble Cedars-Sinai Medical Center
Roland M. du Bois
Roland M. du Bois Imperial College London
Dominique Valeyre
Dominique Valeyre Université Paris Cité
Talmadge E. King
Talmadge E. King University of California, San Francisco
Luca Richeldi
Luca Richeldi Catholic University of the Sacred Heart
Athol U. Wells
Athol U. Wells Imperial College London
Ganesh Raghu
Ganesh Raghu University of Washington
Nobuoki Kohno
Nobuoki Kohno Hiroshima University
Vincent Cottin
Vincent Cottin Claude Bernard University Lyon 1
Steven A. Sahn
Steven A. Sahn Medical University of South Carolina

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Students interested in studying Medicine in the USA have a variety of related online degree and certification pathways to consider. These options offer flexibility and can help launch or advance a healthcare career.

For those looking to become pharmacists, pharm d online programs provide accredited education that meets professional requirements while accommodating busy schedules.

Another growing field is health information management. You can pursue health information technology programs online, preparing for roles in managing electronic medical records and healthcare data.

For quick entry into the workforce, explore options for the cheapest medical coding certification online. This pathway enables job opportunities in medical billing, coding, and insurance processing.

If you’re aiming for advanced patient care roles, check out affordable np programs to become a nurse practitioner. This can open doors to higher responsibilities and salary potential in healthcare settings.

Each of these online options supports different career goals and is designed to make education more accessible and affordable for aspiring healthcare professionals.

Best Scientists Citing Ulrich Costabel

Trending Scientists